
ESTA Stock Forecast & Price Target
ESTA Analyst Ratings
Bulls say
Establishment Labs Hldgs is a leading medical technology company with a disruptive breast implant technology, a strong global presence, and multiple growth drivers. Its U.S. business is the primary growth driver, with consistent growth and increasing account penetration being driven by strong demand for the unique Motiva breast implant brand. Additionally, the company has a diverse pipeline of innovative products and procedures, strong financial performance, and a bullish outlook for future growth. These factors, along with the company's successful marketing of newer, minimally invasive surgery techniques, product iterations and pipeline developments make it a compelling investment opportunity.
Bears say
Establishment Labs Hldgs is experiencing strong revenue growth and positive adjusted EBITDA, but the growth is largely coming from one product - US Motiva. Their international revenue is growing at a slower rate, and there are uncertainties around the approval of their reconstruction label expansion and the success of their minimally invasive platform. Furthermore, their plans for a full US commercial launch of their Preservé product may face challenges in terms of training enough surgeons and converting new patients.
This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.
ESTA Analyst Forecast & Price Prediction
Start investing in ESTA
Order type
Buy in
Order amount
Est. shares
0 shares